litlas
ログインアカウント作成

Charles Dumontet

1995–2025 年に発表

111
論文数
23,554
被引用数
80
h 指数
109
i10 指数

被引用数

Charles Dumontet の年別被引用数1997 年: 被引用 7 件1998 年: 被引用 14 件1999 年: 被引用 30 件2000 年: 被引用 45 件2001 年: 被引用 50 件2002 年: 被引用 60 件2003 年: 被引用 109 件2004 年: 被引用 88 件2005 年: 被引用 114 件2006 年: 被引用 118 件2007 年: 被引用 107 件2008 年: 被引用 119 件2009 年: 被引用 163 件2010 年: 被引用 164 件2011 年: 被引用 165 件2012 年: 被引用 169 件2013 年: 被引用 172 件2014 年: 被引用 140 件2015 年: 被引用 192 件2016 年: 被引用 132 件2017 年: 被引用 188 件2018 年: 被引用 197 件2019 年: 被引用 707 件2020 年: 被引用 753 件2021 年: 被引用 730 件2022 年: 被引用 492 件2023 年: 被引用 430 件2024 年: 被引用 792 件2025 年: 被引用 463 件2026 年: 被引用 13 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,332 件、この内訳の 23.5%中国: 引用元論文 1,115 件、この内訳の 11.2%フランス: 引用元論文 677 件、この内訳の 6.8%イタリア: 引用元論文 550 件、この内訳の 5.6%イギリス: 引用元論文 539 件、この内訳の 5.4%ドイツ: 引用元論文 502 件、この内訳の 5.1%スペイン: 引用元論文 350 件、この内訳の 3.5%カナダ: 引用元論文 291 件、この内訳の 2.9%日本: 引用元論文 263 件、この内訳の 2.7%スイス: 引用元論文 260 件、この内訳の 2.6%オランダ: 引用元論文 258 件、この内訳の 2.6%インド: 引用元論文 229 件、この内訳の 2.3%
0%23.5%その他 25.8%

機関

分野

  • Medicine59.6%
  • Biochemistry, Genetics and Molecular Biology26.6%
  • Chemistry4.9%
  • Immunology and Microbiology3.4%
  • Materials Science1.9%
  • Computer Science0.8%
  • その他2.8%

トピック

  • Monoclonal and Polyclonal Antibodies Research5.1%
  • Multiple Myeloma Research and Treatments4.2%
  • HER2/EGFR in Cancer Research4.1%
  • Protein Degradation and Inhibitors2.8%
  • Lymphoma Diagnosis and Treatment2.5%
  • CAR-T cell therapy research2.5%
  • その他78.8%

共著者

全論文

検索で開く
  1. Antibody–drug conjugates come of age in oncology

    著者: Charles Dumontet, Janice M. Reichert, Peter D. Senter, John M. Lambert, Alain Beck - Nature Reviews Drug Discovery 2023 被引用: 781

  2. Strategies and challenges for the next generation of antibody–drug conjugates

    著者: Alain Beck, Liliane Goetsch, Charles Dumontet, Nathalie Corvaı̈a - Nature Reviews Drug Discovery 2017 被引用: 2,179

  3. Payload diversification: a key step in the development of antibody–drug conjugates

    著者: Louise Conilh, Lenka Sadílková, Warren Viricel, Charles Dumontet - Journal of Hematology & Oncology 2023 被引用: 233

  4. Antibody–Drug Conjugates: The Last Decade

    著者: Nicolas Joubert, Alain Beck, Charles Dumontet, Caroline Denevault‐Sabourin - Pharmaceuticals 2020 被引用: 363

  5. Microtubule-binding agents: a dynamic field of cancer therapeutics

    著者: Charles Dumontet, Mary Ann Jordan - Nature Reviews Drug Discovery 2010 被引用: 1,702

  6. Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases

    著者: Lars Petter Jordheim, David Durantel, Fabien Zoulim, Charles Dumontet - Nature Reviews Drug Discovery 2013 被引用: 1,200

  7. Lenalidomide Maintenance after Stem-Cell Transplantation for Multiple Myeloma

    著者: Michel Attal, Valérie Lauwers‐Cancès, Gérald Marit, Denis Caillot, Philippe Moreau, Thierry Façon, Anne Marie Stoppa, Cyrille Hulin, Lofti Benboubker, Laurent Garderet, Olivier Decaux, Serge Leyvraz, Marie‐Christiane Vekemans, Laurent Voillat, Mauricette Michallet, Brigitte Pegourié, Charles Dumontet, Murielle Roussel, Xavier Leleu, Claire Mathiot, Catherine Payen, Hervé Avet‐Loiseau, Jean‐Luc Harousseau - New England Journal of Medicine 2012 被引用: 1,153

  8. Preclinical Activity of the Type II CD20 Antibody GA101 (Obinutuzumab) Compared with Rituximab and Ofatumumab In Vitro and in Xenograft Models

    著者: Sylvia Herter, Frank Herting, Olaf Mundigl, Inja Waldhauer, Tina Weinzierl, Tanja Fauti, Gunter Muth, Doris Ziegler-Landesberger, Erwin van Puijenbroek, Sabine M. Lang, Minh Ngoc Duong, Lina Reslan, Christian A. Gerdes, Thomas Friess, Ute Baer, Helmut Burtscher, Michael Weidner, Charles Dumontet, Pablo Umaña, Gerhard Niederfellner, Marina Bacac, Christian Klein - Molecular Cancer Therapeutics 2013 被引用: 359

  9. The molecular make up of smoldering myeloma highlights the evolutionary pathways leading to multiple myeloma

    著者: Eileen M. Boyle, Shayu Deshpande, Ruslana G. Tytarenko, Cody Ashby, Yan Wang, Michael Bauer, Sarah K. Johnson, Christopher P. Wardell, Sharmilan Thanendrarajan, Maurizio Zangari, Thierry Façon, Charles Dumontet, Bart Barlogie, Arnaldo Arbini, Even H Rustad, Francesco Maura, Ola Landgren, Fenghuang Zhan, Frits van Rhee, Carolina Schinke, Faith E. Davies, Gareth J. Morgan, Brian A. Walker - Nature Communications 2021 被引用: 138

  10. Monodisperse polysarcosine-based highly-loaded antibody-drug conjugates

    著者: Warren Viricel, Guy Fournet, Sabine Beaumel, Emeline Perrial, Sébastien Papot, Charles Dumontet, Benoı̂t Joseph - Chemical Science 2019 被引用: 93

  11. Exatecan Antibody Drug Conjugates Based on a Hydrophilic Polysarcosine Drug-Linker Platform

    著者: Louise Conilh, Guy Fournet, Eric Fourmaux, Angélique Murcia, Eva‐Laure Matera, Benoı̂t Joseph, Charles Dumontet, Warren Viricel - Pharmaceuticals 2021 被引用: 64

  12. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

    著者: Hervé Avet‐Loiseau, Michel Attal, Philippe Moreau, Catherine Guérin‐Charbonnel, Frédéric Garban, Cyrille Hulin, Serge Leyvraz, Mauricette Michallet, Ibrahim Yakoub‐Agha, Laurent Garderet, Gérald Marit, Lucienne Michaux, Laurent Voillat, Marc Renaud, B. Grosbois, Gaëlle Guillerm, Lotfi Benboubker, M. Monconduit, Catherine Thiéblemont, Philippe Casassus, Denis Caillot, Anne‐Marie Stoppa, Jean‐Jacques Sotto, Marc Wetterwald, Charles Dumontet, Jean‐Gabriel Fuzibet, I Azaïs, Véronique Dorvaux, Marc Zandecki, Régis Bataille, Stéphane Minvielle, Jean‐Luc Harousseau, Thierry Façon, Claire Mathiot - Blood 2007 被引用: 905

  13. SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies

    著者: Jutta Deckert, Marie-Cécile Wetzel, Laura M. Bartle, Anna Skaletskaya, Victor S. Goldmacher, François Vallée, Qing Zhou-Liu, Paul Ferrari, Stéphanie Pouzieux, Charlotte Lahoute, Charles Dumontet, Adriana Pleșa, Marielle Chiron, Pascale Lejeune, Thomas Chittenden, Peter U. Park, Véronique Blanc - Clinical Cancer Research 2014 被引用: 329

  14. Triptolide is an inhibitor of RNA polymerase I and II–dependent transcription leading predominantly to down-regulation of short-lived mRNA

    著者: Stéphane Vispé, Luc DeVries, Laurent Créancier, Jérôme Besse, Sophie Bréand, David J. Hobson, Jesper Q. Svejstrup, Jean-Philippe Annereau, Didier Cussac, Charles Dumontet, Nicolas Guilbaud, Jean‐Marc Barret, Christian Bailly - Molecular Cancer Therapeutics 2009 被引用: 186

  15. The fat and the bad: Mature adipocytes, key actors in tumor progression and resistance

    著者: Minh Ngoc Duong, Aline Geneste, Frédérique Fallone, Xia Li, Charles Dumontet, Catherine Muller - Oncotarget 2017 被引用: 181

  16. Engineering therapeutic bispecific antibodies using CrossMab technology

    著者: Christian Klein, Wolfgang Schäfer, Jörg T. Regula, Charles Dumontet, Ulrich Brinkmann, Marina Bacac, Pablo Umaña - Methods 2018 被引用: 140

  17. The Antitumor Activity of Combinations of Cytotoxic Chemotherapy and Immune Checkpoint Inhibitors Is Model-Dependent

    著者: Chloé Grasselly, Morgane Denis, Aurore Bourguignon, Nolan Talhi, Doriane Mathé, Anne Tourette, Laurent Serre, Lars Petter Jordheim, Eva Laure Matera, Charles Dumontet - Frontiers in Immunology 2018 被引用: 128

  18. Nucleoside analogues and nucleobases in cancer treatment

    著者: Carlos M. Galmarini, John R. Mackey, Charles Dumontet - The Lancet Oncology 2002 被引用: 606

  19. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study

    著者: Fanny Chasseloup, Isabelle Bourdeau, Antoine Tabarin, Daniela Regazzo, Charles Dumontet, Nataly Ladurelle, Lucie Tosca, Larbi Amazit, Alexis Proust, Raphael Scharfmann, Tiphaine Mignot, Frédéric Fiore, Stylianos Tsagarakis, Dimitra Vassiliadi, Dominique Maiter, Jacques Young, Anne-Lise Lecoq, Vianney Deméocq, Sylvie Salenave, Hervé Lefebvre, Lucie Cloix, Philippe Emy, Rachel Dessailloud, Delphine Vezzosi, Carla Scaroni, Mattia Barbot, Wouter de Herder, François Pattou, Martine Tétreault, Gilles Corbeil, Margot Dupeux, Benoit Lambert, Gérard Tachdjian, Anne Guiochon-Mantel, Isabelle Beau, Philippe Chanson, Say Viengchareun, André Lacroix, Jérôme Bouligand, Peter Kamenický - The Lancet Diabetes & Endocrinology 2021 被引用: 77

  20. Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP)

    著者: Camille Lehuédé, Xia Li, Stéphanie Dauvillier, Charlotte Vaysse, Camille Franchet, Emily Clement, David Estève, Mélanie Longué, Léonor Chaltiel, Sophie Le Gonidec, Ikrame Lazar, Aline Geneste, Charles Dumontet, Philippe Valet, Laurence Nieto, Frédérique Fallone, Catherine Muller - Breast Cancer Research 2019 被引用: 132

  21. Germline Lysine-Specific Demethylase 1 ( LSD1/KDM1A ) Mutations Confer Susceptibility to Multiple Myeloma

    著者: Xiaomu Wei, M. Nieves Calvo-Vidal, Siwei Chen, Gang Wu, María V. Revuelta, Jian Sun, Jinghui Zhang, Michael F. Walsh, Kim E. Nichols, Joseph Vijai, Carrie Snyder, Celine M. Vachon, James McKay, Shuping Wang, David Jayabalan, Lauren Jacobs, Dina Becirovic, Rosalie Griffin, Mykyta Artomov, Agnès Viale, Jayeshkumar Patel, Jude M. Phillip, Selina Chen‐Kiang, Karen Curtin, Mohamed E. Salama, Djordje Atanackovic, Rubén Niesvizky, Ola Landgren, Susan L. Slager, Lucy A. Godley, Jane E. Churpek, Judy E. Garber, Kenneth C. Anderson, Mark J. Daly, Robert G. Roeder, Charles Dumontet, Henry T. Lynch, Charles G. Mullighan, Nicola J. Camp, Kenneth Offit, Robert J. Klein, Haiyuan Yu, Leandro Cerchietti, Steven M. Lipkin - Cancer Research 2018 被引用: 82

  22. In Vivo Syngeneic Tumor Models with Acquired Resistance to Anti–PD-1/PD-L1 Therapies

    著者: Morgane Denis, Chloé Grasselly, Pierre‐Antoine Choffour, Anne Wierinckx, Doriane Mathé, Kamel Chettab, Anne Tourette, Nolan Talhi, Aurore Bourguignon, Fabian Birzele, Elsa Kress, Lars Petter Jordheim, Christian Klein, Eva‐Laure Matera, Charles Dumontet - Cancer Immunology Research 2022 被引用: 32

  23. A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages

    著者: Iseulys Richert, Paul BERCHARD, Lhorra Abbes, А. В. Новиков, Kamel Chettab, Alexandra Vandermoeten, Charles Dumontet, Marie Karanian, Jérôme Kerzerho, Martine Caroff, Jean‐Yves Blay, Aurélie Dutour - Cancers 2023 被引用: 18

  24. Dysregulation of Ribosome Biogenesis and Translational Capacity Is Associated with Tumor Progression of Human Breast Cancer Cells

    著者: Stéphane Belin, Anne Béghin, Eduardo Solano-Gonzàlez, Laurent Bezin, Stéphanie Brunet-Manquat, Julien Textoris, Anne‐Catherine Prats, Hichem C. Mertani, Charles Dumontet, Jean‐Jacques Diaz - PLoS ONE 2009 被引用: 228